New products are an essential component of our range. Introductions are made on an ongoing basis, with hundreds of new small molecules, peptides and antibodies being added every year. Our aim is to find the latest, otherwise unobtainable research tools, and bring them to the market as quickly as we can.
| Cat.No. | Product Name | Activity |
| 5335 | Angiotensin A | Potent endogenous vasoconstrictor peptide - derivative of angiotensin II (Cat. No. 1158) |
| 5315 | Rostafuroxin | Antihypertensive agent; Na+/K+ ATPase modulator |
| 5310 | ASP 3026 | Potent anaplastic lymphoma kinase (ALK) inhibitor |
| 5285 | ZLN 024 hydrochloride | Allosteric AMPK activator |
| 5283 | HLM 006474 | E2F transcription factor inhibitor |
| 5040 | SB 706504 | p38 MAPK inhibitor |
| 4518 | EPPTB | Trace amine 1 (TA1) receptor antagonist/inverse agonist |
| 5325 | Rosiglitazone | Potent and selective PPARγ agonist; antidiabetic agent. |
| 5313 | LY 315920 | Selective secreted phospholipase A2 (sPLA2) inhibitor |
| 5272 | MK 0677 | High affinity ghrelin receptor agonist |
| 5266 | BAZ2-ICR | Selective BAZ2 bromodomain inhibitor |
| 4958 | Eplivanserin hemifumarate | Potent and selective 5-HT2A antagonist |
| 5289 | OF 1 | Selective BRPF1B and BRPF2 bromodomain inhibitor |
| 5261 | Dimethylenastron | Inhibitor of mitotic motor kinesin Eg5 |